Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Wages, Salaries and Other
Others
Ratios

Revolution Medicines (RVMD) Shares Outstanding (Diluted Average) (2020 - 2025)

Historic Shares Outstanding (Diluted Average) for Revolution Medicines (RVMD) over the last 6 years, with Q3 2025 value amounting to $189.2 million.

  • Revolution Medicines' Shares Outstanding (Diluted Average) rose 1341.83% to $189.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $189.2 million, marking a year-over-year increase of 1341.83%. This contributed to the annual value of $167.7 million for FY2024, which is 4824.38% up from last year.
  • Latest data reveals that Revolution Medicines reported Shares Outstanding (Diluted Average) of $189.2 million as of Q3 2025, which was up 1341.83% from $188.6 million recorded in Q2 2025.
  • Revolution Medicines' 5-year Shares Outstanding (Diluted Average) high stood at $189.2 million for Q3 2025, and its period low was $72.8 million during Q4 2021.
  • Over the past 5 years, Revolution Medicines' median Shares Outstanding (Diluted Average) value was $108.1 million (recorded in 2023), while the average stood at $121.6 million.
  • In the last 5 years, Revolution Medicines' Shares Outstanding (Diluted Average) surged by 120.01% in 2022 and then surged by 7370.64% in 2024.
  • Revolution Medicines' Shares Outstanding (Diluted Average) (Quarter) stood at $72.8 million in 2021, then increased by 10.74% to $80.6 million in 2022, then surged by 40.34% to $113.1 million in 2023, then surged by 48.24% to $167.7 million in 2024, then grew by 12.81% to $189.2 million in 2025.
  • Its Shares Outstanding (Diluted Average) was $189.2 million in Q3 2025, compared to $188.6 million in Q2 2025 and $188.1 million in Q1 2025.